Skip to content

Trel-X Gel TXG10

by Integra Lifesciences Corp.

Trel-X Gel TXG10, a human-derived demineralized bone matrix implant (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Integra Lifesciences Corp., was cleared under FDA 510(k) K040419 on 25 Mar 2005 and listed in FDA GUDID on 22 Sep 2015 (UDI-DI 10381780114369); the registry lists it as not in commercial distribution (GUDID) as of 16 Nov 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 16 Nov 2026

Documents

510(k) K040419

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 16 Nov 2026.

Regulatory status

as of registry sync 16 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10381780114369 UDI-DI Date22 Sep 2015ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK040419 Date25 Mar 2005DecidedStatusActive

Official records

From the FDA record

Device description
Trel-X™Gel, 10cc is human bone that has been demineralized and combined with poloxamer reverse phase medium which is formulated into a gel or putty-like form. Trel-X is provided in a sterile, single patient use package.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 16 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K040419 decided 25 Mar 2005 Active
  • FDA GUDID UDI-DI 10381780114369 listed 22 Sep 2015 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K040419
  2. Listed FDA GUDID 10381780114369

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Trel-X Gel
Generic name
Human-derived demineralized bone matrix implant
Model / Ref / Catalog
TXG10
Primary DI / UDI-DI
10381780114369
510(k) Number
FDA product code
MQV
GMDN term
Human-derived demineralized bone matrix implant
Device class
Class II
Regulation number
888.3045
GUDID distribution status
Not in Commercial Distribution

Similar devices

Other devices filed under FDA product code MQV (FILLER, BONE VOID, CALCIUM COMPOUND).

Other devices from Integra Lifesciences Corp.

See all devices from Integra Lifesciences Corp. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • HCT/P
  • Lot / batch number
  • Expiration date
Other properties (8, all answered No)